Jia, Lee

Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas

Kummar, S., Chen, A., Ji, J., Zhang, Y., Reid, J. M., Ames, M., Jia, L., Weil, M., Speranza, G., Murgo, A. J., et al. (2011) · Cancer Research

PARP inhibition in cancer therapyCancer therapeutics and mechanisms

Cited by 259

Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer

Li, F., Mei, H., Gao, Y., Xie, X., Nie, H., Li, T., Zhang, H., & Jia, L. (2017) · Biomaterials

Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery

Cited by 152

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Lian, S., Xie, R., Ye, Y., Lu, Y., Cheng, Y., Xie, X., Li, S., & Jia, L. (2019) · Scientific Reports

Cancer Immunotherapy and BiomarkersPhagocytosis and Immune Regulation

Cited by 81

Biostable Aptamer Rings Conjugated for Targeting Two Biomarkers on Circulating Tumor Cells in Vivo with Great Precision

Dong, H., Han, L., Wu, Z.-S., Zhang, T., Xie, J., Ma, J., Wang, J., Li, T., Gao, Y., Shao, J., et al. (2017) · Chemistry of Materials

Advanced biosensing and bioanalysis techniquesDendrimers and Hyperbranched Polymers

Cited by 36